These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10858081)

  • 1. Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay.
    Yoshida EM; Sherlock CH
    Liver Transpl; 2000 May; 6(3):386. PubMed ID: 10858081
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.
    Angus PW; McCaughan GW; Gane EJ; Crawford DH; Harley H
    Liver Transpl; 2000 Jul; 6(4):429-33. PubMed ID: 10915163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
    Markowitz JS; Martin P; Conrad AJ; Markmann JF; Seu P; Yersiz H; Goss JA; Schmidt P; Pakrasi A; Artinian L; Murray NG; Imagawa DK; Holt C; Goldstein LI; Stribling R; Busuttil RW
    Hepatology; 1998 Aug; 28(2):585-9. PubMed ID: 9696028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation.
    Rosenau J; Tillmann HL; Bahr MJ; Trautwein C; Boeker KH; Nashan B; Klempnauer J; Manns MP
    Transplant Proc; 2001; 33(7-8):3637-8. PubMed ID: 11750544
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver transplantation and management of the hepatitis B virus. Preface.
    Rizzetto M
    Dig Liver Dis; 2009 May; 41 Suppl 2():S183. PubMed ID: 19482254
    [No Abstract]   [Full Text] [Related]  

  • 6. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
    Dodson SF; de Vera ME; Bonham CA; Geller DA; Rakela J; Fung JJ
    Liver Transpl; 2000 Jul; 6(4):434-9. PubMed ID: 10915164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine.
    Lee KW; Lee SK; Joh JW; Kim SJ; Park JH; Chon SE; Choi SH; Heo JS; Paik SW; Koh KW; Lee JH; Choi MS; Kim YI; Lee BB
    Transplant Proc; 2001; 33(7-8):3643-4. PubMed ID: 11750547
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B immune globulin: the US experience.
    Pruett TL; McGory R
    Clin Transplant; 2000; 14 Suppl 2():7-13. PubMed ID: 10965958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin.
    Karliova M; Malago M; Trippler M; Valentin-Gamazo C; Rothaar T; Broelsch CE; Gerken G; Treichel U
    Transplant Proc; 2002 Dec; 34(8):3319-22. PubMed ID: 12493460
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of hepatitis B in liver transplant patients.
    Mohanty SR; Cotler SJ
    J Clin Gastroenterol; 2005 Jan; 39(1):58-63. PubMed ID: 15599213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients.
    Ben-Ari Z; Mor E; Bar-Nathan N; Shaharabani E; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2003 Mar; 35(2):609-11. PubMed ID: 12644066
    [No Abstract]   [Full Text] [Related]  

  • 13. Indefinite passive immunization after liver transplantation for hepatitis B.
    Pruett T
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S88-9. PubMed ID: 12362305
    [No Abstract]   [Full Text] [Related]  

  • 14. Posttransplantation prevention and treatment of recurrent hepatitis B.
    Rizzetto M; Marzano A
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S47-51. PubMed ID: 11084085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
    Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
    Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination for hepatitis B after transplantation: a realistic goal?
    Pruett T
    Hepatology; 2002 Jan; 35(1):235-7. PubMed ID: 11786982
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts.
    Perrillo RP
    Clin Transplant; 2000; 14 Suppl 2():25-8. PubMed ID: 10965961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
    Schiff E; Lai CL; Hadziyannis S; Neuhaus P; Terrault N; Colombo M; Tillmann H; Samuel D; Zeuzem S; Villeneuve JP; Arterburn S; Borroto-Esoda K; Brosgart C; Chuck S;
    Liver Transpl; 2007 Mar; 13(3):349-60. PubMed ID: 17326221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.
    Perrillo R; Rakela J; Dienstag J; Levy G; Martin P; Wright T; Caldwell S; Schiff E; Gish R; Villeneuve JP; Farr G; Anschuetz G; Crowther L; Brown N
    Hepatology; 1999 May; 29(5):1581-6. PubMed ID: 10216146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.